89 related articles for article (PubMed ID: 8624237)
1. Ipriflavone, an antiostheophorotic agent.
Böcskei Z; Simon K; Varga M; Hermecz I
Acta Crystallogr C; 1996 Apr; 52 ( Pt 4)():1022-4. PubMed ID: 8624237
[TBL] [Abstract][Full Text] [Related]
2. [The ipriflavone story].
György L; Mihály N; Marian EP; István H
Acta Pharm Hung; 1995 Nov; 65(6):191-4. PubMed ID: 8742624
[TBL] [Abstract][Full Text] [Related]
3. [Forced stability study of ipriflavone].
Magdolna VM; Kálmán S; Imola R; Tünde ET; István H
Acta Pharm Hung; 1995 Nov; 65(6):203-7. PubMed ID: 8742626
[TBL] [Abstract][Full Text] [Related]
4. [Place of ipriflavone in the therapy of osteoporosis].
Zsuzsanna B
Acta Pharm Hung; 1995 Nov; 65(6):229-32. PubMed ID: 8742631
[TBL] [Abstract][Full Text] [Related]
5. Ipriflavone as an inhibitor of human cytochrome P450 enzymes.
Monostory K; Vereczkey L; Lévai F; Szatmári I
Br J Pharmacol; 1998 Feb; 123(4):605-10. PubMed ID: 9517377
[TBL] [Abstract][Full Text] [Related]
6. 5-Acetyl-2-amino-6-methyl-4-phenyl-4H-pyran-3-carbonitrile and 2-amino-5-benzoyl-6-methyl-4-phenyl-4H-pyran-3-carbonitrile acetonitrile solvate.
Nesterov VN; Wiedenfeld DJ; Nesterova SV; Hastings LF
Acta Crystallogr C; 2006 Dec; 62(Pt 12):o705-8. PubMed ID: 17148918
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of ipriflavone (TC-80) in rats.
Yoshida K; Tsukamoto T; Torii H; Doi T; Naeshiro I; Uemura I; Tanayama S
Radioisotopes; 1985 Nov; 34(11):612-7. PubMed ID: 3834523
[TBL] [Abstract][Full Text] [Related]
8. The effect of ipriflavone and its main metabolites on theophylline biotransformation.
Monostory K; Vereczkey L
Eur J Drug Metab Pharmacokinet; 1996; 21(1):61-6. PubMed ID: 8839679
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, antiproliferative, and antiplatelet activities of oxime- and methyloxime-containing flavone and isoflavone derivatives.
Wang TC; Chen IL; Lu PJ; Wong CH; Liao CH; Tsiao KC; Chang KM; Chen YL; Tzeng CC
Bioorg Med Chem; 2005 Nov; 13(21):6045-53. PubMed ID: 15990314
[TBL] [Abstract][Full Text] [Related]
10. [Characterization of ipriflavone structure by instrumental examination].
Gábor H; Zsolt B; Tünde ET; Péter F; Imola R; Kálmán S; Ildikó S; István H
Acta Pharm Hung; 1995 Nov; 65(6):209-13. PubMed ID: 8742627
[TBL] [Abstract][Full Text] [Related]
11. Ipriflavone metabolite-III inhibits LPS-induced nitric oxide release from RAW-264.7 cells.
Koncz S; Horváth EJ
Acta Physiol Hung; 1996; 84(3):223-8. PubMed ID: 9219593
[TBL] [Abstract][Full Text] [Related]
12. Ipriflavone inhibits osteolytic bone metastasis of human breast cancer cells in a nude mouse model.
Iwasaki T; Mukai M; Tsujimura T; Tatsuta M; Nakamura H; Terada N; Akedo H
Int J Cancer; 2002 Aug; 100(4):381-7. PubMed ID: 12115517
[TBL] [Abstract][Full Text] [Related]
13. [Ipriflavone].
Kitatani K; Morii H
Nihon Rinsho; 1998 Jun; 56(6):1537-43. PubMed ID: 9648478
[TBL] [Abstract][Full Text] [Related]
14. N-H···O and N-H···N interactions in three pyran derivatives.
Vishnupriya R; Suresh J; Sivakumar S; Kumar RR
Acta Crystallogr C; 2013 Jun; 69(Pt 6):642-6. PubMed ID: 23744387
[TBL] [Abstract][Full Text] [Related]
15. Concise synthesis of 2, 3-diarylpyrimido[1,2-a]benzimidazole based on isoflavones.
Zhang ZT; Qiu L; Xue D; Wu J; Xu FF
J Comb Chem; 2010 Mar; 12(2):225-30. PubMed ID: 20039759
[TBL] [Abstract][Full Text] [Related]
16. [Overview of clinical studies with ipriflavone].
Attila BK
Acta Pharm Hung; 1995 Nov; 65(6):223-8. PubMed ID: 8742630
[TBL] [Abstract][Full Text] [Related]
17. [Effects of ipriflavone on bone loss induced by GnRH analog].
Pellicano M; Morgera R; Affinito P; Di Carlo C; Napolitano V; Merlino P; Tremolaterra F; Palomba S; Nappi C
Minerva Ginecol; 1996 Oct; 48(10):435-9. PubMed ID: 9005368
[TBL] [Abstract][Full Text] [Related]
18. X-ray single-crystal analysis of (-)-(S)-equol isolated from rat's feces.
Liang G; Zhang T; Wang J; Chen B; Cheng K; Hu C
Chem Biodivers; 2005 Jul; 2(7):959-63. PubMed ID: 17193187
[TBL] [Abstract][Full Text] [Related]
19. Ipriflavone: an important bone-building isoflavone.
Head KA
Altern Med Rev; 1999 Feb; 4(1):10-22. PubMed ID: 9988779
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Micellization Mechanism of an Amphipathic Graft Copolymer with Enhanced Solubility of Ipriflavone.
Tanida S; Kurokawa T; Sato H; Kadota K; Tozuka Y
Chem Pharm Bull (Tokyo); 2016; 64(1):68-72. PubMed ID: 26726747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
